Authors:
XYNOGALOS S
PETRAKI K
KOMPOROZOS V
PETRAKI C
SKREKAS G
PAPAKONSTANTINOU E
VASLAMATZIS M
ALEXOPOULOS CG
Citation: S. Xynogalos et al., BC12, P53 ONCOPROTEINS AND KI67 PROLIFERATION INDEX EXPRESSION IN COLORECTAL-CANCER (CRC), Annals of oncology, 9, 1998, pp. 176-176
Authors:
VASLAMATZIS M
PETRAKI C
PETRAKI K
PAPAKONSTANTINOU E
GREGORAKIS A
PARASKEVAKOU H
DAVARIS P
SOTSIOU F
ALEXOPOULOS C
Citation: M. Vaslamatzis et al., SMALL-CELL CARCINOMA OF THE URINARY-BLADDER - CLINICAL, CLINICOPATHOLOGICAL, IMMUNOHISTOCHEMICAL AND ULTRASTRUCTURAL CHARACTERISTICS IN 5 CASES, Annals of oncology, 9, 1998, pp. 310-310
Authors:
VASLAMATZIS M
XYNOGALOS S
RONTOGIANNI D
VARTHALITIS J
MESISKLIS P
VAMVOUKA C
ALEXOPOULOS CG
Citation: M. Vaslamatzis et al., DEMOGRAPHIC, CLINICAL CHARACTERISTICS AND DISTRIBUTION OF HISTOLOGICAL SUBTYPES IN 196 PATIENTS (PTS) - THE EXPERIENCE OF THE DEPARTMENT OFMEDICAL ONCOLOGY, EVANGELISMOS-HOSPITAL, ATHENS, GREECE, Annals of oncology, 9, 1998, pp. 513-513
Authors:
VASLAMATZIS M
PETRAKI C
PAPACHRISTODOULOU A
PAPAYANNI E
ALEXOPOULOS CG
Citation: M. Vaslamatzis et al., PROGNOSTIC-SIGNIFICANCE OF VARIOUS IMMUNOHISTOCHEMICAL MARKERS IN INVASIVE UROTHELIAL CANCER OF THE BLADDER (UCCB), European journal of cancer, 31A, 1995, pp. 1164-1164
Citation: S. Xynagalos et al., ONDANSETRON (ODS) PLUS METOCLOPRAMIDE (MTP) PLUS DEXAMETHASONE (DXM) VS ONDANSETRON PLUS DEXAMETHASONE DURING CDDP BASED CHEMOTHERAPY (CT), European journal of cancer, 31A, 1995, pp. 1252-1252
Authors:
ECONOMOPOULOS T
STATHAKIS N
ALEXOPOULOS C
PAVLIDIS N
CONSTANTINIDOU M
BRIASSOULIS E
PAPAGEORGIOU E
DERVENOULAS J
PAPPA V
VASLAMATZIS M
RAPTIS S
Citation: T. Economopoulos et al., 2ND MALIGNANCIES FOLLOWING TREATMENT FOR HODGKINS-DISEASE - A GREEK EXPERIENCE, Haematologica, 79(3), 1994, pp. 273-276